Korea Atherosclerosis Study-3 (KAS3)

This study is currently recruiting participants.

Verified January 2012 by Seoul National University Bundang Hospital

Sponsor:

Information provided by (Responsible Party):

Soo Lim, Seoul National University Bundang Hospital

ClinicalTrials.gov Identifier:

NCT01168362

First received: July 22, 2010

Last updated: January 9, 2012

Last verified: January 2012

History of Changes

Tracking Information

First Received Date ^ICMJE

July 22, 2010

Last Updated Date

January 9, 2012

Start Date ^ICMJE

February 2006

Estimated Primary Completion Date

March 2012 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

Presence of coronary artery disease [ Time Frame: 5 years ] [ Designated as safety issue: No ]

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT01168362 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Mortality [ Time Frame: 5 years ] [ Designated as safety issue: No ]

Original Secondary Outcome Measures ^ICMJE

Same as current

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Korea Atherosclerosis Study-3

Official Title ^ICMJE

Evaluation of Coronary Artery Disease With Multidetector-Row Cardiac Computed Tomography in Positive Cardiovascular Risk or Not

Brief Summary

Multidetector-row Computed Tomography (CT) has been introduced for use in the diagnosis of coronary heart disease. The investigators aimed to characterize coronary artery disease in subjects with cardiovascular risk or not, and in particular plaque natures depending on different status of cardiovascular risk. Especially,the investigators will evaluate the relationships between the pericardial fat and severity of stenosis as well as plaque characteristics using logistic regression models.

Detailed Description

Not Provided

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Observational Model: Cohort
Time Perspective: Prospective

Target Follow-Up Duration

Not Provided

Biospecimen

Retention: Samples Without DNA

Description:

Biochemical paramteres including lipid, glucose, insulin, and other novel cardiometabolic factors

Sampling Method

Probability Sample

Study Population

positive cardiovascular risks or not

Condition ^ICMJE

Cardiovascular Diseases
Cardiovascular Mortality
All-cause Mortality

Intervention ^ICMJE

Not Provided

Study Group/Cohort (s)

High risk group
positive cardiovascular risk group
Low risk group
negative cardiovascular risk group

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Estimated Enrollment ^ICMJE

4000

Estimated Completion Date

May 2012

Estimated Primary Completion Date

March 2012 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Korean capable of Multidetector-Row Cardiac Computed Tomography (MDCT)

Exclusion Criteria:

malignancy
infection
shock

Gender

Both

Ages

18 Years to 90 Years

Accepts Healthy Volunteers

Yes

Contacts ^ICMJE

Contact: Soo Lim, MD,PHD

82-31-787-7035

limsoo@snu.ac.kr

Location Countries ^ICMJE

Korea, Republic of

Administrative Information

NCT Number ^ICMJE

NCT01168362

Other Study ID Numbers ^ICMJE

M10642140004-06N4214

Has Data Monitoring Committee

Responsible Party

Soo Lim, Seoul National University Bundang Hospital

Study Sponsor ^ICMJE

Seoul National University Bundang Hospital

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

Soo Lim, MD,PHD

Seoul National University Bundang Hospital

Information Provided By

Seoul National University Bundang Hospital

Verification Date

January 2012

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top